Infants exhibiting profound metabolic ketoacidosis, muscular hypotonia, developmental retardation, and who have very large accumulations of methylmalonic acid in their blood and urine suffer from a disorder known as methylmalonic acidemia. This disorder results from a defect in which of the following enzymes?
Answer(s): C
Defects in methylmalonyl-CoA mutase activity comprise four distinct genotypes whose clinical symptoms are remarkably similar. Characteristic findings in methylmalonyl-CoA mutase deficiency include failure to thrive leading to developmental abnormalities, recurrent vomiting, respiratory distress, hepatomegaly, and muscular hypotonia. In addition, patients have severely elevated levels of methylmalonic acid in the blood and urine. Unaffected individuals have near undetectable levels of methylmalonate in their plasma, whereas, affected individuals have been found to have levels ranging from 3 to 40 mg/dL in their blood.Deficiency in alpha-ketoacid dehydrogenase (choice A) results in MSUD, so named because of the characteristic odor of the urine in afflicted individuals. Mental retardation in the MSUD is extensive.Deficiency in homogentisic acid oxidase (choice B) results in alkaptonuria. Alkaptonuria results from the accumulation of homogentisic acid, a byproduct of tyrosine catabolism, in the urine and tissues. Oxidation of homogentisate in the urine causes it to turn dark and in the tissues results in ochronosis, which refers to the ochre color of the deposits in connective tissue, bones, and other organs. Deficiency in phenylalanine hydroxylase (choice D) results in PKU which results in severe mental retardation if not detected and treated properly. Deficiency in tyrosine aminotransferase (choice E) results in eye, skin, and neurologic symptomology. The neurologic symptoms are similar to those seen in PKU.
Following a minor respiratory illness, a seemingly healthy, developmentally normal 15-month-old boy exhibited repeated episodes of severe lethargy and vomiting following periods of fasting, such as during the middle of the night. The parents brought the infant to the emergency room following a seizure. The child was hypoglycemic and was administered 10% dextrose, but remained lethargic. Blood ammonia was high, liver function tests were slightly elevated, and his serum contained an accumulation of dicarboxylic acids. Only low levels of ketones were detecteable in the urine. This infant suffers from which of the following disorders?
Deficiency in MCAD is the most common inherited defect in the pathways of mitochondrial fatty acid oxidation. The most common presentation of infants with this disorder is episodic hypoketotic hypoglycemia following periods of fasting. Although the first episode may be fatal, and incorrectly ascribed to sudden infant death syndrome, patients with MCAD deficiency are normal between episodes and are treated by avoidance of fasting and treatment of acute episodes with intravenous glucose. Accumulation of acylcarnitines (dicarboxylic acids) is diagnostic, in particular octanoylcarnitine. Glutaric acidemia type II (choice A) results from a defect in electron transfer flavoproteinubiquinone oxidoreductase and presents with symptoms of hypoketotic hypoglycemia as in the case of MCAD deficiency. However, this disorder manifests within the first 2448 h after birth and is frequently associated with congenital anomalies. Lesch- Nyhan syndrome (choice B) results from a defect in HGPRT--an enzyme involved in nucleotide metabolism. Symptoms of Lesch-Nyhan syndrome include hyperuricemia, bizarre neurobehavioral manifestations, growth retardation, and anemia. Deficiency in PDH (choice D) results in lactic acidemia, which can be quite severe at birth leading to neonatal fatality. Milder deficiency results in lactic acidemia associated with profound psychmotor retardation. Cori disease (choice E) results from a defect in the glycogen debranching enzymes. Clinical features include hepatomegaly, hypoglycemia, skeletal myopathy and short stature, and cardiomyopathy.
A 28-year-old man has the following symptoms: diffuse grayish corneal opacities, anemia, proteinuria, and hyperlipemia. Renal function is normal and serum albumin level is only slightly elevated. Plasma triglycerides and unesterified cholesterol levels are elevated, as are levels of phosphatidylcholine. These symptoms are indicative of which lipoproteinassociated disorder?
Answer(s): D
Two familial syndromes directly involve defects in LCAT. Familial LCAT deficiency is characterized by near complete absence of the enzyme activity from the plasma. Fish eye disease is characterized by an absence of LCAT activity toward high-density lipoproteins (HDLs) but presence of activity toward LDLs.Clinical features of familial LCAT deficiency include corneal opacities, anemia, and proteinuria. Due to the lack of LCAT activity, the plasma level of esterified cholesterol is lower than normal and phosphatidylcholine (the principal source of fatty acid for esterification to cholesterol) levels are higher than normal. The profile of all classes of plasma lipoproteins in patients with familial LCAT deficiency is abnormal. Bassen-Kornzweig syndrome (choice A), also identified as abetalipoproteinemia, is due to a defect in apo B expression. Clinical symptoms include retinitis pigmentosa, ataxic neuropathy, and erythrocytes that appear thorny (acanthocytosis). FH (choice B) is characterized by reduced LDL clearance, which leads to severe hypercholesterolemia. Major clinical symptoms are arterial deposition of LDL-cholesterol, which leads to atherosclerosis and coronary artery disease. Deposition of LDL- cholesterol is also seen in tendons and skin resulting in xanthomas. Familial hypertriacylglycerolemia (choice C), also identified as hyperlipoproteinemia type IV, is a form of LPL deficiency. The defect leads to increased levels of circulating VLDLs and is associated with glucose intolerance and hyperinsulinemia. This disorder is frequently associated with Type II diabetes. Wolman disease (choice E) is cholesterol ester storage disease that leads to massive accumulation of cholesteryl esters and triglycerides in most tissues.This disease is almost always fatal within the first year of life and thus would not be present in a 28-year- old.
A 23-year-old man sees his physician to ask about the recent appearance of several large closely spaced bumps on his elbows. Suspecting that these are fatty eruptions, the physician tests the man's blood for lipid, cholesterol, and lipoprotein levels. Results show elevated cholesterol and triglycerides and the presence of a variant form of very low-density lipoprotein (VLDL) identified as beta-migrating VLDL (- VLDL). Amore careful analysis of the biochemical properties of the apoproteins associated with the beta- VLDL particles identifies a form of apo E that has a more negative charge than apo E from normal individuals. These results indicate the individual is afflicted with which of the following hyperlipoproteinemias?
Familial dysbetalipoproteinemia (type III hyperlipoproteinemia) results from a genetic variant in the apo E gene that causes poor interaction of chylomicron remnants and VLDLs with the apo E receptor. This results in the presence, in the serum, of beta-migrating VLDL (- VLDLs), which are cholesterol- rich remnants of both intestinal chylomicrons and hepatic VLDL. Diagnosis of type III hyperlipoproteinemia is indicated by elevated plasma cholesterol and triglyceride, xanthomas (fatty eruptions under the skin), and of course the presence of -VLDL. Type I hyperlipoproteinemia (choice A) results from defects in the activity or activation of LPL and results in the massive accumulation of chylomicrons in the plasma. The disease is usually detected in childhood following recurrent attacks of abdominal pain, hepatosplenomegaly, and pancreatitis.Familial hypercholesterolemia (choice B) is the result of defects in the LDL receptor. The defects lead to characteristic elevation in LDL, deposition of LDL-derived cholesterol in the tendons and skin and in the arteries. Individuals homozygous for defective LDL receptors have severe hypercholesterolemia (6501000 mg/dL) and coronary heart disease begins early in childhood with death caused by myocardial infarct before the age of 20. Type IV hyperlipoproteinemia (choice D) is associated with overproduction VLDLs. An associated glucose intolerance and hyperinsulinemia are also seen in this disorder. Wolman disease (choice E) is caused by a deficiency in lysosomal acid lipase and results in massive accumulation of cholesteryl esters and triglycerides in most tissues. The disease is almost always fatal before the age of 1 year.
I-cell disease (also identified as mucolipidosis type II) is characterized by the presence of inclusion bodies in fibroblasts (hence the derivation of the term I-cell), severe psychomotor retardation, corneal clouding, and dystosis multiplex. These symptoms arise from a defect in the targeting of lysosomal enzymes due to an inability to carry out which of the following processes?
Answer(s): A
Enzymes that are destined for the lysosomes (lysosomal enzymes) are directed there by a specific carbohydrate modification. During transit through the Golgi apparatus a residue of Nacetylglucosamine- 1- phosphate is added to carbon 6 of one or more specific mannose residues that have been incorporated into these enzymes. The N-acetylglucosamine is activated by coupling to UDP and is transferred by an Nacetylglucosamine phosphotransferase yielding N-acetylglucosamine-1- phosphate-6-mannoseprotein. A second reaction removes the Nacetylglucosamine leaving mannose residues phosphorylated in the sixth position. Aspecific mannose-6-phosphate receptor is present in the membranes of the Golgi apparatus.Binding of mannose-6-phosphate to this receptor targets proteins to the lysosomes. Defects in the proper targeting of glycoproteins to the lysosomes can also lead to clinical complications. Deficiencies in N- acetylglucosamine phosphotransferase lead to the formation of dense inclusion bodies in fibroblasts. Two disorders related to deficiencies in the targeting of lysosomal enzymes are termed I-cell disease (mucolipidosis II) and pseudo-Hurler polydystrophy (mucolipidosis III). I-cell disease is characterized by severe psychomotor retardation, skeletal abnormalities, coarse facial features, painful restricted joint movement, and early mortality. Pseudo- Hurler polydystrophy is less severe; it progresses more slowly, and afflicted individuals live to adulthood. Each of the other choices (B, C, D, and E) represent other potential pathways that are not affected in the processing, delivery, or presentation of lysosomal enzymes or the receptors that recognize the properly processed enzymes.
Post your Comments and Discuss USMLE STEP1 exam prep with other Community members:
Our website is free, but we have to fight against AI bots and content theft. We're sorry for the inconvenience caused by these security measures. You can access the rest of the STEP1 content, but please register or login to continue.